Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Surgery,
Ellis Fischel Cancer Center,
Molecular Microbiology and Immunology
Xiaoqiang Qi has not added Biography.
If you are Xiaoqiang Qi and would like to personalize this page please email our Author Liaison for assistance.
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.
Journal of hepatology Jan, 2017 | Pubmed ID: 27520877
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Gastroenterology 03, 2018 | Pubmed ID: 29408569
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer.
Journal of immunology research and therapy , 2018 | Pubmed ID: 30123861
Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death.
Cancer letters Jul, 2019 | Pubmed ID: 31004701
University of Missouri-Columbia
Xiaoqiang Qi*,1,2,3,
Emily Schepers*,1,2,
Diego Avella1,2,
Eric T. Kimchi1,2,
Jussuf T. Kaifi1,2,
Kevin F. Staveley-O'Carroll1,2,
Guangfu Li1,2,3
1Department of Surgery, University of Missouri-Columbia,
2Ellis Fischel Cancer Center, University of Missouri-Columbia,
3Molecular Microbiology and Immunology, University of Missouri-Columbia
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır